Exosomes and Tissue Engineering: Developing Novel Therapies for Lung Disease
Thomas Petersen, M.D., Ph.D. is Vice President of Regenerative Medicine at United Therapeutics in Research Triangle Park, N.C. His team is developing cell- and tissue-based therapies for lung diseases with a particular focus on pulmonary hypertension and bronchopulmonary dysplasia. Dr. Petersen graduated magna cum laude and Phi Beta Kappa from Princeton University with a BSE in Electrical Engineering and a certificate in Bioengineering. He then graduated from the Duke School of Medicine medical scientist training program with his M.D. degree and a Ph.D. in Biomedical Engineering. He conducted postdoctoral research at Yale University in the Departments of Biomedical Engineering and Anesthesia. During his graduate and postdoctoral work, Dr. Petersen developed novel tissue engineering techniques to generate functional lung tissue in rodent models. As part of this research, he developed the first transplantable and functional engineered lung, and the results of this innovative work were published in Science. His work was recognized by TIME magazine as one of the best inventions of 2010 and by CNN as a Top Innovation of 2010.